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Abstract
Aim The rising prevalence of bronchial asthma has led to
world-wide efforts to understand and stem this develop-
ment. Cross-sectional studies appear to show that early
childhood use of antibiotics may be an important contribu-
tory factor, with paracetamol as an additional suspected
cause. However, mounting evidence, which is reviewed
here, points to various confounding factors as the major
reasons for these reported associations.
Methods PubMed and EMBASE were systematically
searched for studies on associations between antibiotics
and/or paracetamol with asthma and/or wheezing, published
up to November 2012. A total of 64 pertinent studies were
identified, 35 focusing on antibiotics, 19 on paracetamol,
and ten addressing both antibiotics and paracetamol, bring-
ing the number of relevant datasets to 74.
Results Numerous studies were cross-sectional and made no
adjustment for the indication of antibiotics or paracetamol;
consequently, they were unable to dismiss possible con-
founding by indication. Where such adjustments could be
performed (mostly in longitudinal studies), they substantial-
ly weakened or entirely eliminated the association with
asthma or asthma surrogates present in the unadjusted data.
Conclusion The weight of evidence of the collected studies in
our review strongly suggests that the association of antibiotics
with childhood asthma reflects various forms of bias, the most
prominent of which is confounding by indication. Recent
studies and meta-analyses support the same conclusion for
paracetamol. Truly indicated antibiotics should not be with-
held from infants or young children for fears they might
develop asthma. Likewise, there is no sound reason to replace
paracetamol as the preferred pain relief and fever medication
in this age group.
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Introduction
The highly complex pathogenesis of bronchial asthma leaves
little room for simple answers and remedies. This setting has
led to the formulation of hypotheses aimed at providing
straightforward explanations and may explain the eager ac-
ceptance of results from numerous, mostly cross-sectional
studies postulating causative roles for medications, such as
antibiotics and paracetamol, used in pregnancy or early child-
hood. The nature of the factors involved in bronchial asthma
—a disease of worldwide importance, possibly linked to drugs
with universally high exposure levels—makes such a possi-
bility highly intriguing, and if true would call for clear con-
sequences. It is the scope of this review to appraise the
available evidence. As the abundance of reiterative publica-
tions has a propensity to obscure the general picture and
possibly impede the identification of higher quality studies,
we have undertaken a comprehensive appraisal following
predefined rules, with the view to structuring the published
work according to the level of evidence. Further, the wealth of
dedicated work and publications made it advisable to narrow
the focus to exposure in early childhood.
Methods
PubMed and EMBASE were searched up to 1 November
2012 using two different sets of terms: (1) (antibiotic or
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antibact) and (asthma or wheez) and (children or childhood)
and (study or trial); (2) (paracetamol or acetaminophen) and
(asthma or wheez) and (children or childhood), and (study
or trial). Twenty-six additional studies were found by
searching reference lists of relevant articles.
In total, 1,288 papers were found. In the first assessment
round, guidelines, review articles, letters and comments, and
duplicated publications/listings were discarded, as well as
non-English articles and papers addressing conditions other
than asthma or wheeze or focusing onmanagement rather than
risk factors (Fig. 1). In a second assessment round of ‘fine-
tuning’, duplicated or interim publications and papers study-
ing the effects of pregnancy rather than childhood exposure,
lacking differentiation between adults and children, address-
ing conditions other than asthma or wheeze, analyzing sales
rather than individual drug intake, or focusing on transient
wheeze only were discarded. This left 64 studies for consid-
eration, among which ten studies reported on both antibiotics
and paracetamol (Fig. 1). Of the numerous birth cohort stud-
ies, those including cases after the incident were classified as
retrospective, while those identifying cases after recruitment
were considered to be prospective.
Of the outcome parameters and results, only wheeze and
asthma were considered and listed. While other outcomes,
such as eczema and allergic disposition, were studied and
reported, these might support or speak against associations,
but are not decisive for this review.
How to identify asthma in children
Wheezing alone does not justify a diagnosis of asthma in
preschool children. As early as 1995, Martinez and col-
leagues [1] emphasized that infant wheezing is mostly tran-
sient; only in a minority of cases do early wheezing episodes
indicate a probability to develop asthma. More recent guide-
lines and consensus reports [2–4] reflect this view. Wheez-
ing shows a prevalence of almost 50 % in children aged
6 years and is in most cases associated with frequently
recurring viral infections of the upper respiratory tract.
Thus, even recurrent wheeze is not equivalent to asthma.
The majority of participants of the European Respiratory
Society task force [4] abstained from using the term asthma
to describe preschool wheezing illness. A further uncertain-
ty lies in the understanding and use of the term “wheezing”
among parents [3, 4]. Frequently a diagnosis is possible only
through long-term follow-up and by observing the child’s
response to specific treatments [2].
It follows that studies which are based on questionnaires
asking parents about wheeze in children of preschool age
are of dubious value. This includes the International Study
of Asthma andAllergies in Childhood (ISAAC) protocol
that was basically laid out in 1995 by Asher [5], a method-
ology that essentially relies on questionnaires to be com-
pleted by adolescents (13–14 years of age) at school, or at
home by the parents of children aged 6–7 years. In Phase II,
this was supplemented by questionnaires covering suspected
risk factors, including drugs (see website for more details:
http://isaac.auckland.ac.nz/). Current views hold that paren-
tally reported wheeze should be confirmed by a healthcare
professional [3], bearing in mind that not all healthcare
workers are equally accurate in estimating the severity of
wheeze [4]. Asthmatic disease could be suspected in chil-
dren with a history of >3 episodes of reversible bronchial
obstruction documented within the previous 6 months [2].
Also, a history of asthma prescription drugs suggests (but
does not prove) that asthma was diagnosed.
Factors that might set the stage for asthma development
There is a plethora of hazards suspected to promote child-
hood asthma, including findings in the neonate and parental
factors or indicators [6–15]. The notion is evolving that
epigenetic changes affecting the developing immune system
may be the common pathway to many purported causes [8,
16]. Of the invoked postnatal influences, viral infections of
the respiratory tract in early life deserve special attention [7,Fig. 1 Study selection for systematic review
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8, 17–21]. Early life in this context denotes infancy, i.e., the
period between birth and 2–3 years.
Prospective epidemiologic studies have shown that up to
80 % of asthma exacerbations in children are associated
with viral upper respiratory infections [22]. The underlying
mechanisms have not been resolved. Alterations of cytokine
balance of the infant lung by early respiratory viral infec-
tions have been discussed; mediation by epigenetic changes
in inflammatory pathways is an attractive—though unprov-
en—hypothesis [16, 20].
Thus, observational studies face the enormous challenge
of adjusting for the appropriate confounders, with no guar-
antee that the identified risk figures are free of residual
confounding. Even worse, the accumulated consequences
of several unmeasured confounders with small or moderate
effects may be able to produce a sizable contortion of the
outcome of interest [23]. Integration of many factors leading
to increased susceptibility, rather than invocation of a mono-
causal increase in exposure to one of the classical asthma
risk factors, may be required for a full understanding [24].
Antibiotics
Our literature search on the relationship between antibiotic
use in early childhood and later occurrence of asthma equiv-
alents (wheeze) and asthma diagnosis identified 45 studies
(Table 1).
Cross-sectional studies
All 20 cross-sectional studies were integrated into or in-
spired by ISAAC (Table 1) and reported some forms of
association between early use of antibiotics and wheezing
and/or asthma. In ten of the studies, a causal association was
considered likely; in one case there was no statistically
significant association [25]; in two studies the authors
avoided making such a conclusion [26] or linked a possible
risk to a special disposition [27]; in five reports the associ-
ation was either not discussed [28, 29], discussed with some
scepticism [30, 31], or explained by confounding factors
[32]; in one study, the association vanished when the odds
ratios (OR) were adjusted [33]. Similarly, Wjst et al. [34]
considered reverse causation to be the most likely explana-
tion of associations between the use of antibiotics and
wheezing/diagnosis of asthma. This conclusion was sup-
ported by a substudy in which parents were asked about
the indication for use of asthma medication. The association
with asthma vanished when only non-pulmonary indications
were considered, and the OR for wheeze was substantially
reduced.
Two case–control studies nested in birth cohort studies
also fall into the category of cross-sectional studies. No clear
conclusion on the association with antibiotics was offered
by Martel et al. [35], whereas Thomas et al. [36] reported
that more cases than controls had received antibiotics during
the first year of life and had been prescribed antibiotics for
lower respiratory tract infection during the first 3 years of
life. Statistical significance was borderline and was found
only for prescriptions over the whole 3-year period [OR
1.47, 95 % confidence interval (CI) 1.01–2.13]. Conspicu-
ously, no difference was noted in single-year comparisons,
including the important period between 0 and 1 year of age.
Longitudinal studies
Markedly different conclusions on antibiotic-induced risk of
childhood asthma were drawn by the authors of four retro-
spective birth cohort studies [37–40], of which the authors
of only one study recognized a significant association [37].
The notion arrived at by the authors of the remaining three
studies was that the observed associations were best attrib-
uted to various kinds of bias. McKeever et al. [38] reported
small associations that could largely be explained by con-
sulting behavior. Children with asthma were more likely to
have early respiratory tract infections. These authors con-
sidered that the association might be more in keeping with
reverse than true causation. Two additional studies are illus-
trated in Fig. 2. Cullinan et al. [39] collected self-reports of
asthma and compared them with contemporary medical
records. The use of antibiotics in the first 5 years of life
was associated with later asthma, but only when antibiotics
were prescribed for lower respiratory infections. No associ-
ation was found with non-respiratory infections. The authors
considered reverse causation bias as the most plausible
explanation. Almqvist et al. [40] distinguished between anti-
biotics typically used for airway and non-airway infections.
Only the former group was associated with a significant
hazard ratio (HR), and the authors concluded that there
was reverse causation or confounding by indication due to
respiratory tract infections.
Nineteen prospective birth cohort studies were found
(Table 1), yielding a similar picture. In five studies, a causal
association was suspected. No discrimination between anti-
biotics could be determined in two of these [41, 42]; in two
other studies, associations were found to be limited to cer-
tain antibiotic subgroups [43, 44]; in the last study a small
risk was concluded by Marra et al. [45], but refuted by the
same group in a later study [46].
Two studies reached more or less equivocal conclusions.
Mitchell et al. [47] felt that their data strengthened the
hypothesis of a causal relationship, but acknowledged the
possibility of confounding by indication. In the second
further study, the possibilities of causation and of confound-
ing by indication were given similar weights [48].
Various forms of bias strongly arguing against an associa-
tion were identified in the remaining 12 prospective birth
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Beasley et al. [77]; involved
no adjustment for
respiratory infections)
Causal association considered likely
Kwon and Lee [78]; Wickens et al. [79]; Awasthi et al. [80] (also acknowledged possibility of various types of
bias); Cohet et al. [81]; Ahn et al. [82] (suggested an association with fever, antibiotics, and acute gastroenteritis
during infancy); Floistrup et al. [83]; Foliaki et al. [84]; Karimi and Mirzaei [85]; Mitchell et al. [86]; Sobko et
al. [25] (small number of cases; no statistical significance of association, only slight association in crude OR);
Yeh et al. [87] (associations with respiratory infections and antipyretics (addressed as mostly paracetamol, no
quantification) and strong temporal association with kindergarten entry suggest confounding by indication)
No conclusion of causal association
Von Mutius et al. [26] (discussed various kinds of bias and were cautious to conclude a causative role of
antibiotics)
Risk in case of special disposition considered
Droste et al. [27] (very weak association (OR1.7; CI 1.0-3.1); concluded that antibiotics put those children at risk,
who are genetically predisposed to atopic immune responses)
Association reported, rather explained by reverse causation
Wjst et al. [34] (considered reverse causation the most likely possible explanation, but did not exclude true
causation; for antibiotic use in non-pulmonary disease, the association vanished for asthma and weakened for
wheezing)
Association visible in data, undiscussed
Sharma and Banga [28] (weak association (OR 1.6, CI 1.1–2.1)); Del-Rio-Navarro et al. [29]
No association in adjusted OR, undiscussed
Castro-Rodriguez et al. [33]
Association discussed with scepticism
Barragan-Meijueiro et al. [30]; Garcia et al. [31]
Association explained by confounding factors
Rusconi et al. [32]
Case–control Studies,
Nested in a Birth
Cohort Study
Association reported, no clear conclusion
Martel et al. [35] (discussed confounding by indication, recall bias, and reverse causation bias as possible
confounders)
Causal association considered likely for broad-spectrum antibiotics
Thomas et al. [36] (association weak (OR 1.47, CI 1.01-2.13), low number of cases; reverse causation not
excluded)
Retrospective Birth Cohort
Studies (Cases of interest
identified after the incident)
Concluded a causal association
Kozyrskvj et al. [37] (antibiotics in the first year of life associated with asthma at 7 years; adjustment for lower
respiratory infections reduced the association, restriction to children in an urban environment deleted it for unknown
reasons; remaining association weak (OR 1.05, CI 1.02–1.09); confounding by indication remains a possibility)
Association rather explained by confounding factors
McKeever et al. [38] (small effects, that could be explained to a large extent by consulting behaviour); Cullinan et
al. [39] (association confined to lower respiratory infections and not observed in non-respiratory infections; cf.
Fig. 2); Almqvist et al. [40] (hazard ratios for typical airway antibiotics much stronger than for non-airway
antibiotics; cf. Fig. 2)
Causal association concludedProspective Birth Cohort
Studies (Cases of interest
identified after recruitment)
Alm et al. [41] (studied age group (until 12 months) does not allow firm conclusions on asthma; no adjustment
for respiratory infections, confounding by indication still possible); Risnes et al. [42] (interview 6 years after
birth, recall bias possible); Goksör et al. [43] (broad spectrum antibiotics were considered causative, no details;
confounding by indication possible due to lack of information on infectious diagnosis); Jedrychowski et al. [44]
(when adjusted for respiratory infections, the Odds ratio lost statistical significance; macrolide and
cephalosporin associations lost strength, but retained significance; considered that immuno-modulation might
underlie asthma promotion by (certain) antibiotics); Marra et al. [45] (after excluding children with upper or
lower respiratory infection the hazard ratio still showed a small association between antibiotics and asthma (but
cf. Marra et al. [46], below));
Causal association as well as confounding by indication considered
Mitchell et al. [47] (no adjustment for airway infections; concluded that antibiotics are a risk factor but
considered confounding by respiratory infections); Kummeling et al. [48] (no adjustment for airway infections;
in a later overview, the same authors suggested confounding by indication (Kummeling and Thijs [66]))
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cohort studies, or no association was detected at all (Table 1).
Of this subset, five studies may serve as instructive examples.
Three of these are illustrated in Fig. 2. Adjustment for typical
confounding factors [49] or respiratory infections in the his-
tory of the patients [50, 51] led to sizable to dramatic decreases
in the respective OR, which in each case lost their statistical
significance. In a study by Illi et al. [56], antibiotics given for
lower respiratory tract infections were excluded from the
analysis, which probably explains the absence of an associa-
tion between childhood antibiotics and a later diagnosis of
asthma. Finally, Harris et al. [52] tested associations for respi-
ratory and non-respiratory infections separately. All associa-
tions observed with early use of antibiotics were weak, and
non-respiratory infections associations, slight or borderline,
were detected in only two of the six analyzed age brackets
(Table 1).
Association between the use of paracetamol in early
childhood and development of bronchial asthma
There are numerous non-randomized studies, both prospec-
tive and retrospective, which report findings supporting the
notion that exposure to paracetamol in the first years of life,
and/or the year preceding data collection, is associated either
with diagnoses of asthma at the age of 5–6 years or later, or
at least with signs (mainly wheezing), which suggest a
propensity for developing adult-type asthma at a later date.
Cross-sectional studies
Our literature search identified 29 relevant studies. The
majority of these (21) are cross-sectional, of which 19
form part of or were designed in keeping with ISAAC
Table 1 (continued)
Reference (Comments)
Association explained by confounding factors or no associations found
Marra et al. [46] (considered that antibiotics were used for asthmatic wheeze (reverse causation)); Kusel et al.
[49] (concluded that the data did not indicate that using antibiotics early in life led to asthma at 5 years; cf. Fig.
2); Celedon et al. [50] (association of antibiotics in the first year of life with asthma persistent at age of 5 years;
lost significance after adjustment for lower respiratory infections; concluded that findings do not support
association between antibiotic use in early life and childhood asthma; cf. Fig. 2); Mai et al. [51] (concluded that
the association could at least partially be explained by early respiratory infection; cf. Fig. 2); Harris et al. [52]
(concluded there was no plausible causative relationship with subsequent respiratory allergies including
wheeze); Ponsonby et al. [88] (no association between antibiotic use in the first month of life and childhood
asthma); Illi et al. [89] (reported lower respiratory tract infections in the first 3 years of life associated with
wheeze; no association with antibiotics); Celedon et al. [90] (findings do not support association between
antibiotic use in the first year of life and persistent wheezing or asthma at the age of 5); Verhulst et al. [91]
(concluded from lack of temporal associations that association between wheezing and antibiotics most likely
reflected reverse causation); Wickens et al. [92] (suggested that the effect of antibiotics on respiratory disease
may be due to confounding by chest infections); Dom et al. [93] (the association was described as negative, i.e.
a protective effect of antibiotics); Su et al. [94] (concluded that at least a major portion of the association may be
an artefact of the strong relation of illness visits to a doctor to both antibiotic use and risk for asthma diagnosis)
A more detailed and annotated version including patient numbers is given in the Electronic Supplementary Material (Table 3)
Fig. 2 Influence of data
collection and analysis on the
association between childhood
or adult asthma and the use of
antibiotics in early life. Graph is
presented as odds ratio (OR) or
hazard ratio (HR) values ± the
confidence interval (whiskers).
See Table 1 for details on the
mentioned studies. adj. for resp.
inf. Adjusted for respiratory
infections [39, 40, 49–51]
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(Table 2). All of these studies reported some form of
association. The authors of only two of the ISAAC-type
studies seriously questioned the causality of the detected
association [28] or concluded a major or decisive role
for confounding factors [32]. Of two case–control stud-
ies, the authors of one considered sizable contributions
by various forms of bias [53], the authors of the second
cautioned against distortions by recall bias and reverse
causation [54].
Longitudinal studies
Six prospective birth cohort studies were found. In a first
study [55], use of paracetamol was documented until age 7
years. The primary outcome was asthma at 6–7 years; one of
the secondary outcomes was infantile wheeze. While the
crude data showed that increasing frequency of paracetamol
use was weakly associated with an enhanced risk of child-
hood asthma, this association vanished after adjustment for
frequency of respiratory infections (Fig. 3), strongly sug-
gesting that the data were confounded by indication. As
predictable for such confounding, use of paracetamol for
non-respiratory causes was not associated with asthma [55].
Similar conclusions were drawn by the authors of another
prospective population-based birth cohort study [56] investigat-
ing the association between febrile illnesses and antipyretic
medication during infancy and the later development of allergic
disease. There was a clear distinction between respiratory and
non-respiratory infections. The number of paracetamol treat-
ment courses for gastroenteritis or urinary tract infections did
not differ between asthmatic and non-asthmatic children, con-
trary to expectations were paracetamol to have a pathogenetic
role in asthma. On the other hand, prescriptions for respiratory
tract infections were more frequent in asthmatic than in non-




Beasley et al. [77]; involved no
adjustment for respiratory
infections)
Causal association considered likely
Del-Rio-Navarro et al. [29]; Barragan-Meijueiro et al. [30]; Garcia et al. [31]; Beasley et al. [77]; Cohet et al.
[81]; Floistrup et al. [83] (antipyretics in the first year of life associated with diagnosis of asthma, very slight
association (OR 1.23, CI 1.01-1.51), studied antipyretics, with no distinction between individual drugs; no
association with later use); Mitchell et al. [86]; Yeh et al. [87] (association with antipyretics (addressed as
mostly paracetamol, no quantification); associations with antibiotics and respiratory infections and a strong
temporal association with kindergarten entry suggest confounding by indication); Karimi et al. [95] (where
present, associations where borderline); Kuschnir and Alves de Cunha [96]; Vlaski et al. [97]; Wong et al.
[98]; Foliaki et al. [99] (association with asthma ever very slight (OR 1.16, CI 1.00-1.35); Wang et al. [100];
Beasley et al. [101]; Gonzalez-Barcala et al. [102]
Association visible in data, undiscussed
Castro-Rodriguez et al. [33]
Association explained by confounding factors
Rusconi et al. [32]; Sharma and Banga [28]
Further Cross-sectional Studies,
Case–control Design
Association discussed with scepticism
Koniman et al. [53]; Rodriguez Martinez et al. [54]
Prospective Birth Cohort Studies
(Cases of interest identified after
recruitment)
Causal association considered likely
Amberbir et al. [60] (studied age group does not allow firm conclusions on asthma; adjustment for respiratory
infections hinges on correct recall of symptoms, still leaving the possibility of confounding by indication
and recall bias)
Causal association as well as confounding considered
Bakkeheim et al. [59] (considered reverse causation a possibility because of paracetamol’s association with
history of, but not with, current asthma; association found only after adjusting for gender (girls, not boys));
Wickens et al. [61] (ISAAC questionnaire; considered a possible causal relationship, but also contributions
by recall bias, reverse causation, and confounding by viral respiratory infections; adjustment for chest
infections did not cover the critical period of infancy)
Association explained by confounding factors or no associations found
Lowe et al. [55]; Schnabel et al. [56]; Shaheen et al. [58]
Prospective Studies No risk of hospitalization or equivocal outcome
Lesko and Mitchell [63] (antipyretics not associated with risk of hospitalization for asthma/bronchiolitis);
Lesko et al. [64] (compared paracetamol with ibuprofen; differences might be due to an increased risk after
paracetamol or a decrease after ibuprofen)
A more detailed and annotated version including patient numbers is given in the Electronic Supplementary Material (Table 4)
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asthmatic children. Altogether, in this study usage of paraceta-
mol correlated with the number of febrile days, rather than with
diagnoses of asthma. This result is in agreement with that of a
prospective study, which showed that adolescents diagnosed for
asthma also had a history of more febrile days in early child-
hood than non-asthmatic adolescents [57].
Relevant data are also available from the Avon Longitu-
dinal Study on a population-based birth cohort [58]. Weak
associations in the crude data were reduced to borderline by
careful adjustment for possible confounding factors (with
the exception of airway infections). As infant paracetamol
use was associated with childhood asthma only in children
who had wheezed in infancy (Fig. 3), the authors concluded
that the association may be confounded by pre-existing
wheeze or allergy.
The association between allergic disease and use of para-
cetamol during pregnancy and during the first 6 months of life
was investigated in another longitudinal study [59]. A detailed
questionnaire in the maternity ward and a parental record of
the infant at age 6 months were followed by an outcome
assessment 10 years later. This assessment was essentially
based on ISAAC questions, but with the improvement that
recognition of a history of asthma required interaction with the
health system, deduced from fulfilling two of three relevant
conditions (pertinent symptoms, a physician’s diagnosis of
asthma, use of typical asthmamedication). Crude data showed
no association between paracetamol use during the first
6 months of life and a subsequent history of asthma. Adjusting
for gender revealed an association in girls (but not in boys),
which was insensitive to adjustment for respiratory infections.
However, there was no association with current asthma or
current wheeze, irrespective of adjustments being made or
not. The authors made the point that association with a history
of asthma, but not with current asthma, makes causation
questionable, as the former finding could reflect wheezing
and reverse causation. Paracetamol use during pregnancy
was not associated with any outcomes of interest at 10 years,
including current asthma or history of asthma.
At odds with these studies are the results of the investi-
gation by Amberbir et al. [60] who used data from a
population-based cohort in Ethiopia, followed from preg-
nancy to the age of 3 years. Symptoms of respiratory infec-
tion were surveyed at 2 months and 1 year. According to the
completed ISAAC questionnaires, use of paracetamol in the
first year of life was associated with the incidence of
wheeze, but also with symptoms of respiratory infections.
Adjustment for such symptoms only slightly reduced the
strength of the association. The authors concluded an asso-
ciation between infantile use of paracetamol and an in-
creased risk of incidence of wheeze. It should be noted
that wheezing at 3 years is no safe predictor of later asthma.
Given the technical difficulties of that study, factors such as
recall and misclassification bias or confounding by indica-
tion can probably not be dismissed.
Finally, ambivalent signals come from the study by
Wickens et al. [61]. Due to the use of ISAAC questionnaires
the indications for paracetamol use remain unknown in this
study. For asthma and wheeze at 6 years, an association was
obtained for use of paracetamol between 5 and 6 years of
age (>19 times), but not for early use. For less frequent use
between 5 and 6 years of age (3–10 times), an association
was found for wheeze, not for asthma; adjustment in a
subgroup for chest infections in the period between age 5
and 6 years weakened but did not dissipate the association.
However, as this adjustment did not cover the critical period
of infancy (i.e., between birth and 2 or 3 years), it is not
sufficient to dismiss a role for confounding by indication.
The authors presented an equivocal discussion considering a
causal relationship as well as a role for recall bias, reverse
causation, and confounding by viral respiratory infections.
Thus, while cross-sectional studies on the pathogenesis of
juvenile asthma would suggest a risk of using paracetamol
in early childhood, such risk disappears or is hardly discern-
ible in the majority of longitudinal studies. This notion is
also supported by a birth cohort study (n02,091) that has
been published in abstract form [62] and hence not been
Fig. 3 Influence of data
collection and analysis on the
association between childhood
asthma and use of paracetamol
in early life. Data are presented
as OR values (squares) ± CI
(whiskers). See Table 2 for
study details. inf.
Infancy [55, 58]
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integrated in Table 2. A sizable association between fre-
quent paracetamol use at the age of 4 years and wheeze at
6 years in the Leicester Respiratory Cohorts was evident in
the crude data, but entirely disappeared after adjustment,
among others for respiratory symptoms. The authors sug-
gested that the association could be totally explained by
confounding.
Randomized studies
In a large double blind trial, children in need of antipyretic
treatment, including 47 % with a respiratory infection, were
randomized to receive paracetamol or ibuprofen and fol-
lowed up for hospitalization under a specific diagnosis.
There was no difference between the two drugs in terms of
hospitalization for bronchiolitis or asthma during the 4-week
follow-up period [63]. Using a very similar design, the same
group later studied asthmatic children with febrile disease
[64]. Again, hospitalization for asthma was not different
between the paracetamol and ibuprofen groups. However,
outpatient visits for asthma were more frequent if paraceta-
mol was used for antipyretic treatment during respiratory
infections, but there was no difference for other causes of
fever. The authors concluded that either paracetamol caused
asthmatic symptoms or ibuprofen afforded protection. The
latter alternative would be more appealing, as harmful
effects of paracetamol should not have spared patients with
non-respiratory causes of fever. The short duration of the
study would call for confirmation over longer periods.
Discussion
The 64 studies considered in this review embrace a large
number of cross-sectional reports, which, mostly relying on
the unmodified ISAAC questionnaires, keep being pub-
lished at a steady rate and attract attention, even though
their shortcomings were recognized early.
Despite the increase in knowledge achieved with the
ISAAC methodology, the use of uniform questionnaires
has also perpetuated basic shortcomings. With regard to
antibiotics (and paracetamol, see below), the lack of regard
for the treated disorder is most conspicuous. This is impor-
tant, as the typical indication for the use of antibiotics in
children is fever, frequently caused by respiratory infec-
tions; it seems reasonable to assume that antibiotics are
often administered even though the airway infection is of
viral origin. Thus, any identified association with antibiotics
is at risk of confounding by indication (the putative cause
and effect items are caused by a third event), for which
adjustment is impossible owing to a lack of information.
Other obvious sources of bias, typical of cross-sectional
studies, are recall bias (faulty recollection of past events),
misclassification bias (disagreeing views on the nature of
wheezing and asthma; in some studies mitigated by video
questionnaires), and reverse causation (the temporal order of
events is unclear, so that any putative cause of asthmatic
disease may rather be its consequence).
For good reasons, cross-sectional studies are considered
less conclusive and were consistently excluded from analy-
sis in a recent review [65]. We decided that presenting and
evaluating such studies was the preferable approach to sim-
ply neglecting them. This broad approach also provided
what may be considered a strength of the present overview,
namely, a comprehensive appreciation and appraisal of in-
dividual publications.
Early childhood antibiotics as a cause for asthma
The hypothesis of antibiotic-induced childhood asthma has
been debated since the late 1990s, and several pathome-
chanisms have been invoked. However, this discussion
may be futile, considering the growing consensus that such
apparent associations are mainly due to confounding fac-
tors, especially, as reviewed by Kummeling and Thijs [66],
in the form of recall bias and confounding by indication.
The same group has recently refined their review in a meta-
analysis [65]. Eighteen studies qualified for the overall
meta-analysis. The pooled risk estimate yielded an OR of
1.27 (CI 1.12–1.43), indicating a slight increase in the risk
of developing asthma and/or wheeze after antibiotic use in
the first year of life. Nine of these studies displayed no
overlap between the exposure to antibiotics and the devel-
opment of first wheezing/asthmatic symptoms in the statis-
tical analysis (avoidance of recall bias) and, secondly,
presented OR values adjusted for lower respiratory tract
infections (avoidance of confounding by indication). In this
subset, the pooled OR was 1.12 (CI 0.98–1.26), with the
lower 95 % CI of 0.98 indicating that an OR of 1.0 cannot
be excluded with certainty [65].
The authors of a concurrent systematic review [67] ar-
rived at similar conclusions. Five non-retrospective studies,
which were attributed the greatest validity because of ad-
justment for respiratory infection, yielded a pooled OR of
1.13 (CI 1.10–1.17), suggesting a significant but weak as-
sociation between antibiotic use in early life and childhood
asthma. The discrepancy between this appraisal and that of
Penders et al. [65] can be explained by the fact that the latter
authors [65] included four additional relevant studies, the
majority of which refuted an association between early use
of antibiotics and childhood asthma.
In line with previous reviews [67, 68], the present over-
view shows that the evidence to support a role for antibiotics
in the development of childhood asthma mostly derives
from cross-sectional studies, whereas prospective studies
find no or only weak associations.
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Popular arguments supporting a causation of childhood
asthma by paracetamol
The argumentative basis for a causal role of early childhood
use of paracetamol in asthma development has recently been
summarized [69] (cited in italics below), allowing a point-
by-point inspection of its soundness.
1) The strength of the association. The use of this term
implies that absolute values can denote stronger and
weaker associations. OR of <2 are perceived as small.
The authors of only four of the 19 cross-sectional stud-
ies in Table 2 arrived at OR of >2, and two further
studies, dependent on the studied topic, reported values
of <2 and >2, respectively. Thus, overall, the strength of
the association cannot be considered large.
2) The consistency of the association across age, geogra-
phy, and culture. The authors of the cross-sectional
studies of Table 2 agree that a certain level of confound-
ing cannot be dismissed in their results. Clearly, factors
such as confounding by indication and recall bias will
show consistency across age, geography and culture.
3) The dose–response relationship. Confounding by indi-
cation will show such a relationship: more severe air-
way infections will cause more febrile days. It is self-
evident that more severe febrile illness will prompt a
larger consumption of paracetamol.
4) The timing of increased acetaminophen use and the
asthma epidemic. Coincidence is not causality. In a
recent analysis of the “asthma epidemic,” the authors
concluded that gene–environment interactions probably
involved in the development of asthma include expo-
sure to animals, endotoxins, tobacco smoke, viruses,
ozone, and day-care, among others; no mention was
made of paracetamol [70].
5) The relationship between per-capita sales of acetamin-
ophen and asthma prevalence across countries. As
reported in the original study [71], there was a clear
dichotomy between anglophone and other countries, the
former being responsible for the bulk of the associa-
tions. After controlling for the “anglophone” effect, the
reported associations were greatly attenuated or abol-
ished, and most (including asthma and wheeze) became
non-significant. Thus, there is certainly no association
“across countries” and the argument that “prevalence of
childhood wheezing in 36 countries…is predicted by
each country’s per-capita sales of acetaminophen” [69]
is a misrepresentation of the data.
6) The results of a double-blind trial of ibuprofen and acet-
aminophen for treatment of fever in asthmatic children.
This trial [64] has been discussed above. When antipy-
retics were used for febrile respiratory infections, para-
cetamol was associated with more frequent outpatient
visits for asthma than ibuprofen, whereas no such differ-
ence was seen when other causes of fever were the
indication. Thus, these results do not support a role for
paracetamol in pathogenesis of asthma.
7) The biologically plausible mechanism of glutathione de-
pletion in airway mucosa. Used as a constant topic
throughout the literature, this argument essentially rests
on two publications. In one study [72], human alveolar
macrophages and type II pneumocytes were exposed in
vitro to paracetamol concentrations ranging from 0.05 to
1 mM (7.6– to 151 mg/l). At 0.1 mM (15.1 mg/l, which
approximates typical maximal plasma concentrations in
humans), a 4-h incubation caused decreases in intracellular
glutathione levels by approximately 30 % (read from
original figure) or 20 % (indicated in the text). Similarly,
daily doses of 4×1 g paracetamol, administered for 14 days
to human volunteers, caused reductions in antioxidant
capacity of the blood, which was interpreted as a reduction
in glutathione concentrations. The largest decrease
amounted to 25 %. While these observations are frequent-
ly viewed as indicative of a potential to cause lung injury,
their quantitative relevance is questionable. As discussed
by others [73], plasma concentrations of glutathione dis-
play a diurnal rhythm, with meal-dependent increases,
which span a 21% interval between minimal and maximal
concentrations (1.1 and 1.4 μM, read from figure) [74].
Thus, as fasting is not considered damaging to lung tissue,
the relevance of glutathione depletion by paracetamol to
possible lung injurious actions remains to be shown.
Antibiotics and paracetamol as asthma promoters: comparable
patterns
There are striking similarities between the two therapeutic
modalities that have been put forward as contributors to the
rising prevalence of childhood asthma. Both antibiotics and
paracetamol are frequently administered to treat febrile dis-
ease, and as respiratory infections account for a great deal of
such disorders in infancy and childhood, (co-)prescriptions for
Fig. 4 Confounding by indication. In principle, an association be-
tween the use of antibiotics or paracetamol and later wheezing or
bronchial asthma could be explained by direct causality or by a third
factor (respiratory infection) prompting prescription of antibiotics and/
or paracetamol and at the same time laying the ground for later
wheezing/asthma
Eur J Clin Pharmacol (2013) 69:1197–1209 1205
airway infections are common. At the same time, viral, but
also bacterial respiratory infections are known to set the stage
for asthma development. In hindsight, it has been inevitable
that the flood of cross-sectional studies (22 on antibiotics and
21 on paracetamol in this overview) would detect associations
between these drugs and asthma or asthma equivalents. As
most of these surveys adhered to the ISAAC strategy and
hence failed to seek information about the reason for the drug
prescription, there was no way to adjust for airway infections
and hence no possibility to avoid confounding by indication
(see Fig. 4). Nonetheless, with only few exceptions, the
authors suggested causative associations, admitted but down-
played possible bias, cited plausible pathomechanisms, and
called for controlled studies.
While controlled studies are not available, the results
from properly designed longitudinal cohort studies, al-
though not randomized, shed more light on possible con-
founders. We have evaluated 29 such studies, including 25
prospective birth cohort studies. In 12 of 19 prospective
studies with antibiotics, the authors concluded that distor-
tion by confounding factors explained most or all of the
associations. There were six dissenting studies [41–45], and
with respect to one of these, the authors reached the opposite
conclusion on a later occasion [46]. Moreover, Mitchell et
al. [47], while seeing the case for an antibiotic causation
strengthened, acknowledged the possibility of confounding
by indication. The authors of the remaining study [48]
considered both bias and true causation possible, but sug-
gested confounding by indication in a later overview [66].
Likewise, the authors of three of the six prospective birth
cohort studies on paracetamol concluded either a causative
role for paracetamol [60] or considered it possible with
different levels of caution [59, 61]. The authors of the three
remaining studies [55, 56, 58] reasoned that associations
were essentially due to bias.
Conclusion
There is growing consensus that the hypothesis of early use of
antibiotics promoting asthma in children and adolescents is
unproven and false. The striking consistency between antibi-
otics and paracetamol in these associations strongly argues that
a causative role for paracetamol is also much less relevant than
the results of cross-sectional studies would suggest. That ap-
parent associations are more likely explained by confounding
by indication is also the conclusion drawn by the authors of a
recent commentary [75], referring to possible lessons from the
antibiotic hypothesis. A concise summary has been provided
by the European Medicines Agency’s Pharmacoviligance
Working Party [76] in its recent statement that available evi-
dence does not support a causal relationship between para-
cetamol and asthma in children after exposure in early infancy.
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